Guardant Health, Inc. (GH): Price and Financial Metrics
GH Price/Volume Stats
| Current price | $42.89 | 52-week high | $50.89 |
| Prev. close | $40.64 | 52-week low | $15.81 |
| Day low | $41.01 | Volume | 1,758,800 |
| Day high | $43.09 | Avg. volume | 2,535,851 |
| 50-day MA | $42.51 | Dividend yield | N/A |
| 200-day MA | $31.89 | Market Cap | 5.29B |
GH Stock Price Chart Interactive Chart >
Guardant Health, Inc. (GH) Company Bio
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.
GH Price Returns
| 1-mo | -10.87% |
| 3-mo | 20.41% |
| 6-mo | 70.94% |
| 1-year | 141.77% |
| 3-year | -23.16% |
| 5-year | -32.13% |
| YTD | 40.39% |
| 2024 | 12.94% |
| 2023 | -0.55% |
| 2022 | -72.81% |
| 2021 | -22.39% |
| 2020 | 64.93% |
Continue Researching GH
Want to do more research on Guardant Health Inc's stock and its price? Try the links below:Guardant Health Inc (GH) Stock Price | Nasdaq
Guardant Health Inc (GH) Stock Quote, History and News - Yahoo Finance
Guardant Health Inc (GH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...